Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.
Last trade$0.4705
Day change-$0.0763 (-13.95%)
Day range$0.435 – $0.621
Volume604,718
Market cap$4M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$3.6M
Price / earnings
—
Price / book
1.83×
Price / sales
10.57×
EV / sales
5.57×
EV / EBITDA
-0.64×
Profitability
Earnings per share
-$0.49
Return on assets
-132.34%
Return on equity
-164.11%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.91×
Quick ratio
3.91×
Cash ratio
3.61×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$2.2M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for AMST, quarterly periods
Line item
Q1 FY2027 Sep 30, 2026
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Revenue
$70.22K
$79.1K
$83.33K
$108.05K
$94.3K
$55.76K
$30.69K
$12.76K
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$70.22K
$79.1K
$83.33K
$108.05K
$94.3K
$55.76K
$30.69K
$12.76K
Selling, general and administrative
$672.47K
$919.11K
$633.21K
$688.45K
$653.53K
$745.91K
$546.31K
$931.76K
Research and development
$188.13K
$211.65K
$134.19K
$164.85K
$102.89K
$167.53K
$172.1K
$211.87K
Total operating expenses
$860.6K
$1.13M
$767.4K
$853.3K
$756.42K
$1M
$718.41K
$1.14M
Operating income
-$790.38K
-$1.05M
-$684.07K
-$745.25K
-$662.12K
-$948.55K
-$687.72K
-$1.13M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$774.4K
-$1.04M
-$678.06K
-$732.55K
-$642.27K
-$923.99K
-$663.42K
-$1.12M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$774.4K
-$1.04M
-$678.06K
-$732.55K
-$642.27K
-$923.99K
-$663.42K
-$1.12M
Net income attributable to common shareholders
-$774.4K
-$1.04M
-$678.06K
-$732.55K
-$642.27K
-$923.99K
-$663.42K
-$1.12M
EBITDA
-$710.89K
-$973.8K
-$612.7K
-$677.51K
-$601.68K
-$755.59K
-$587.21K
-$1.02M
Basic earnings per share
-$0.12
-$0.17
-$0.15
-$0.16
-$0.14
-$0.20
-$0.16
-$0.40
Diluted earnings per share
-$0.12
-$0.17
-$0.15
-$0.16
-$0.14
-$0.20
-$0.16
-$0.40
Recent news
Company coverage with links to the original publishers.
Amesite Inc. announced its largest enterprise deployment to date with a 2,700-patient census customer, validating its AI-native NurseMagic™ documentation platform for enterprise-scale operations. The company reported an 18% reduction in operating spend over six quarters while growing its customer base, with strong pipeline momentum including advanced discussions representing several thousand additional patients.
Amesite Inc. (NASDAQ: AMST) closed a $7.8 million concurrent registered direct offering and private placements, raising $2.6 million upfront with up to $5.2 million in potential proceeds from warrant exercises. The offering included common stock priced at $1.435 per share and Series A-1 and A-2 warrants. Insiders including CEO Dr. Ann Marie Sastry participated in the offering. The company plans to use net proceeds for general corporate purposes and working capital.
The healthcare AI market is projected to surge at a 30% compound annual growth rate through 2030, driven by increased investment across hospitals, insurers, and pharma. Companies like Avant Technologies, Amesite, Oracle, Clover Health, and Alphabet are making advancements in AI-powered healthcare solutions.
The healthcare AI market is projected to surge at a 30% compound annual growth rate through 2030, driven by new investments across hospitals, insurers, and pharma. Companies like Avant Technologies, Amesite, Oracle, Clover Health, and Alphabet are making advancements in AI-powered healthcare solutions.
Amesite, a U.S.-based AI-powered enterprise solutions provider, remains unaffected by recent tariffs due to its domestic workforce and infrastructure. The company's NurseMagic solution is seeing increased demand as it helps healthcare providers reduce costs and improve efficiency.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.